6. The ‘Untreatable Frontier’ of Heart Risk

Lp(a) has long been dubbed “one of the last untreatable frontiers of cardiovascular risk”. Until recently, there were no approved medications to lower it, leaving patients and cardiologists frustrated by this stubborn genetic threat. For more expert insight, see the Cleveland Clinic perspective.